Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Remission in early rheumatoid arthritis: predicting treatment response.

Ma MH, Ibrahim F, Walker D, Hassell A, Choy EH, Kiely PD, Williams R, Walsh DA, Young A, Scott DL.

J Rheumatol. 2012 Mar;39(3):470-5. doi: 10.3899/jrheum.110169. Epub 2012 Jan 15.

PMID:
22247360
[PubMed - indexed for MEDLINE]
2.

Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis.

van der Heijde D, Klareskog L, Landewé R, Bruyn GA, Cantagrel A, Durez P, Herrero-Beaumont G, Molad Y, Codreanu C, Valentini G, Zahora R, Pedersen R, MacPeek D, Wajdula J, Fatenejad S.

Arthritis Rheum. 2007 Dec;56(12):3928-39.

PMID:
18050208
[PubMed - indexed for MEDLINE]
Free Article
3.

Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.

van der Woude D, Young A, Jayakumar K, Mertens BJ, Toes RE, van der Heijde D, Huizinga TW, van der Helm-van Mil AH.

Arthritis Rheum. 2009 Aug;60(8):2262-71. doi: 10.1002/art.24661.

PMID:
19644846
[PubMed - indexed for MEDLINE]
Free Article
4.

Prognostic markers of clinical remission in early rheumatoid arthritis after two years of DMARDs in a clinical setting.

Vázquez I, Graell E, Gratacós J, Cañete JD, Viñas O, Ercilla MG, Gómez A, Hernández MV, Rodríguez-Cros JR, Larrosa M, Sanmartí R.

Clin Exp Rheumatol. 2007 Mar-Apr;25(2):231-8.

PMID:
17543147
[PubMed - indexed for MEDLINE]
5.

Towards personalized treatment: predictors of short-term HAQ response in recent-onset active rheumatoid arthritis are different from predictors of rapid radiological progression.

Dirven L, Visser K, Klarenbeek NB, Ewals JA, Han KH, Peeters AJ, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF.

Scand J Rheumatol. 2012 Feb;41(1):15-9. doi: 10.3109/03009742.2011.594964. Epub 2011 Nov 21.

PMID:
22103436
[PubMed - indexed for MEDLINE]
6.
7.

Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.

Smolen JS, Han C, Bala M, Maini RN, Kalden JR, van der Heijde D, Breedveld FC, Furst DE, Lipsky PE; ATTRACT Study Group.

Arthritis Rheum. 2005 Apr;52(4):1020-30.

PMID:
15818697
[PubMed - indexed for MEDLINE]
Free Article
8.

Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis.

van der Kooij SM, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Güler-Yüksel M, Zwinderman AH, Kerstens PJ, van der Lubbe PA, de Beus WM, Grillet BA, Ronday HK, Huizinga TW, Breedveld FC, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2009 Jun;68(6):914-21. doi: 10.1136/ard.2008.092254. Epub 2008 Jul 28.

PMID:
18662933
[PubMed - indexed for MEDLINE]
9.

Remission in early rheumatoid arthritis treated with conventional DMARDs. Results of a two-year follow-up study of El Ayachi Moroccan cohort.

Benbouazza K, Rkain H, Benchekroun B, Amine B, Bzami F, Benbrahim L, Atouf O, Essakalli M, Abouqal R, Dougados M, Hajjaj-Hassouni N.

Joint Bone Spine. 2012 Jan;79(1):43-6. doi: 10.1016/j.jbspin.2011.02.019. Epub 2011 Apr 15.

PMID:
21497534
[PubMed - indexed for MEDLINE]
11.

A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up.

Verstappen SM, van Albada-Kuipers GA, Bijlsma JW, Blaauw AA, Schenk Y, Haanen HC, Jacobs JW; Utrecht Rheumatoid Arthritis Cohort Study Group (SRU).

Ann Rheum Dis. 2005 Jan;64(1):38-43. Epub 2004 May 6.

PMID:
15130899
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.

Hyrich KL, Watson KD, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register.

Rheumatology (Oxford). 2006 Dec;45(12):1558-65. Epub 2006 May 16.

PMID:
16705046
[PubMed - indexed for MEDLINE]
Free Article
13.

Inflammation and damage in an individual joint predict further damage in that joint in patients with early rheumatoid arthritis.

Boers M, Kostense PJ, Verhoeven AC, van der Linden S; COBRA Trial Group. Combinatietherapie Bij Reumatoide Artritis.

Arthritis Rheum. 2001 Oct;44(10):2242-6.

PMID:
11665964
[PubMed - indexed for MEDLINE]
14.

Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study.

Allaart CF, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Breedveld FC, Dijkmans BA; FARR study group.

Clin Exp Rheumatol. 2006 Nov-Dec;24(6 Suppl 43):S-77-82.

PMID:
17083767
[PubMed - indexed for MEDLINE]
15.

Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.

Möttönen T, Hannonen P, Korpela M, Nissilä M, Kautiainen H, Ilonen J, Laasonen L, Kaipiainen-Seppänen O, Franzen P, Helve T, Koski J, Gripenberg-Gahmberg M, Myllykangas-Luosujärvi R, Leirisalo-Repo M; FIN-RACo Trial Group. FINnish Rheumatoid Arthritis Combination therapy.

Arthritis Rheum. 2002 Apr;46(4):894-8.

PMID:
11953964
[PubMed - indexed for MEDLINE]
16.

In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial.

Rezaei H, Saevarsdottir S, Forslind K, Albertsson K, Wallin H, Bratt J, Ernestam S, Geborek P, Pettersson IF, van Vollenhoven RF.

Ann Rheum Dis. 2012 Feb;71(2):186-91. doi: 10.1136/annrheumdis-2011-200038. Epub 2011 Sep 19.

PMID:
21930734
[PubMed - indexed for MEDLINE]
17.

Serum soluble interleukin-2 receptor predicts early remission in patients with recent-onset rheumatoid arthritis treated with a single disease-modifying antirheumatic drug.

Kuuliala A, Leirisalo-Repo M, Möttönen T, Hannonen P, Nissilä M, Kautiainen H, Korpela M, Julkunen H, Hakola M, Repo H; FIN-RACo Trial Group.

Clin Exp Rheumatol. 2005 Mar-Apr;23(2):243-6.

PMID:
15895898
[PubMed - indexed for MEDLINE]
18.

Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.

Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Korpela M, Hakala M, Järvinen P, Ahonen J, Forsberg S, Leirisalo-Repo M; FIN-RACo Trial Group.

Arthritis Rheum. 2005 Jan;52(1):36-41.

PMID:
15641055
[PubMed - indexed for MEDLINE]
Free Article
19.

Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?

El Miedany Y, Youssef SS, El Gaafary M.

J Rheumatol. 2006 Mar;33(3):490-7.

PMID:
16511918
[PubMed - indexed for MEDLINE]
20.

Patients with moderate rheumatoid arthritis (RA) achieve better disease activity states with etanercept treatment than patients with severe RA.

Keystone E, Freundlich B, Schiff M, Li J, Hooper M.

J Rheumatol. 2009 Mar;36(3):522-31. doi: 10.3899/jrheum.080663. Epub 2009 Feb 17.

PMID:
19228659
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk